NCT05815355

Brief Summary

Patients with Crohn's disease (CD) could develop complications such as stricture, intestinal fistula and abdominal abscess. Some CD patients had poor response to medical therapy. The efficacy of exclusive enteral nutrition (EEN) to these adult active CD patients is still unclear. The investigators aim to study the efficacy of EEN in induction of remission in adult active CD patients with complications or poor response to drugs.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2013

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
7.1 years until next milestone

First Submitted

Initial submission to the registry

September 25, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

2.2 years

First QC Date

September 25, 2022

Last Update Submit

April 14, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Clinical remission after 12 weeks EEN

    The Crohn's disease activity index (CDAI)\<150 was taken as achieving clinical remission.

    July 2013 to October 2015

  • Mucosal healing after EEN

    Mucosal healing was assessed under endoscopy with SES-CD.

    July 2013 to October 2015

Secondary Outcomes (4)

  • The high sensitivity C-reactive protein (mg/L) -Inflammatory parameter assessment

    baseline, week 4 and week 12

  • Inflammatory parameter assessment

    baseline, week 4 and week 12

  • The body mass nutritional parameter assessment

    baseline, week 4 and week 12

  • The albumin (g/L)- nutritional parameter assessment

    baseline, week 4 and week 12

Interventions

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All consecutive adult active CD patients followed up in our center and had been diagnosed with disease complications including stricture, intestinal fistula, abdominal abscess or no response to drugs. Patients were recruited from July 2013 to July 2015.

You may qualify if:

  • \>18 years old
  • Patients with CD was diagnosed clinically according to previously established international criteria \[9\]
  • The diagnosis of stricture, fistula and abdominal abscess was confirmed by ultrasound, CT enterography (CTE), and endoscopy. The bowel stricture should mainly cause by inflammation. Intolerance or failure to steroids or IFX was judged by medical history
  • The disease was in an active period.

You may not qualify if:

  • Intolerant to EEN or need emergency surgery
  • The bowel stricture should mainly cause by fibrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending physician

Study Record Dates

First Submitted

September 25, 2022

First Posted

April 18, 2023

Study Start

July 1, 2013

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

April 18, 2023

Record last verified: 2023-04